Monday, July 02, 2018 3:09:47 PM
Recent CTSO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2025 01:34:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2025 01:33:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2025 01:32:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2025 01:31:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2025 01:29:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 02:05:31 PM
- CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering • GlobeNewswire Inc. • 01/13/2025 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/07/2025 06:26:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 09:31:41 PM
- CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai • GlobeNewswire Inc. • 01/06/2025 12:00:00 PM
- CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue • GlobeNewswire Inc. • 01/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:05:10 PM
- CytoSorbents Rights Offering Begins • GlobeNewswire Inc. • 12/23/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2024 12:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 01:00:13 PM
- CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week • GlobeNewswire Inc. • 12/12/2024 12:00:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 12/09/2024 12:18:15 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/09/2024 12:17:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 12:08:06 PM
- CytoSorbents Announces Rights Offering • GlobeNewswire Inc. • 12/09/2024 12:00:00 PM
- CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/26/2024 12:00:00 PM
- CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:10:58 PM
- CytoSorbents Reports Third Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 11/07/2024 09:05:00 PM
- CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification • GlobeNewswire Inc. • 11/04/2024 12:00:00 PM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM